Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma. (11th December 2018) - Hussain, M. Junaid; Robinson, Myra M.; Hamadeh, Issam; Arnall, Justin; Bhutani, Manisha; Atrash, Shebli; Friend, Reed; Pineda‐Roman, Mauricio; Symanowski, James T.; Usmani, Saad Z.; Voorhees, Peter M.